Emerging Technologies to Achieve Oral Delivery of GLP-1 and GLP-1 Analogs for Treatment of Type 2 Diabetes Mellitus (T2DM)

Canadian Journal of Biotechnology
doi 10.24870/cjb.2017-000107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Science Planet Inc.